Traction-assisted endoscopic submucosal resection (TA-ESD) for rectal neuroendocrine tumors: a randomized multi-center trial

牵引辅助内镜黏膜下切除术(TA-ESD)治疗直肠神经内分泌肿瘤:一项随机多中心试验

阅读:2

Abstract

BACKGROUND AND AIM: Endoscopic resection is the first-line choice for the treatment of rectal neuroendocrine tumors (NETs). This study aimed to compare the efficacy and safety of a modified traction-assisted endoscopic submucosal resection (TA-ESD) and traditional endoscopic submucosal resection (ESD). METHODS: In this multi-center prospective randomized controlled trial, patients with small rectal NET(< 2 cm) were 1:1 randomized into TA-ESD or traditional ESD groups. The operation time was selected as the primary endpoint, while en bloc resection rate, R0 resection rate, complications, length of hospitalization were chosen as secondary endpoints. RESULTS: A total of 44 patients (22 TA-ESD and 22 ESD patients) were enrolled in this study, of which 40 patients (19 TA-ESD and 21 ESD patients) were pathologically confirmed rectal NET patients. The median operation time was shorter in the TA-ESD group than in the ESD group (7.3 (5.4-9.6) vs. 12.2 (7.8-21.0) minutes, Difference (95% CI) -4.5 (-10.0, -1.3), P = 0.0054). Furthermore, the rates of en bloc resection and R0 resection were 22 (100%) and 22 (100%) in TA-ESD group and ESD group, respectively. Perforation occurred in one patient in the ESD group during the operation and no postoperative complication was recorded in both groups. CONCLUSION: Compared with traditional ESD, modified TA-ESD is more suitable for the treatment of small rectal NETs than traditional ESD due to its shorter operation time and improved R0 resection rate.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。